Acute Cerebrovascular Accidents
|
0.360 |
Biomarker
|
disease |
BEFREE |
Patients received alteplase up to 9 hours after the onset or on awakening based on automated perfusion imaging. sICH was ascertained using ECASS II (The Second European-Australasian Acute Stroke Study) criteria.
|
31394994 |
2019 |
Acute Cerebrovascular Accidents
|
0.360 |
Biomarker
|
disease |
BEFREE |
In the absence of active bleeding or known malignancy of the central nervous system, intravenous alteplase seems a reasonable option for patients with an active cancer and acute stroke.
|
31288236 |
2019 |
Acute Cerebrovascular Accidents
|
0.360 |
Biomarker
|
disease |
BEFREE |
Effects of alteplase for acute stroke according to criteria defining the European Union and United States marketing authorizations: Individual-patient-data meta-analysis of randomized trials.
|
29171359 |
2018 |
Acute Cerebrovascular Accidents
|
0.360 |
Biomarker
|
disease |
BEFREE |
Symptoms of acute stroke and MS can overlap and the lack of clear clinical/radiological criteria that alert the patient or clinician to the development of acute stroke in an MS patient compound the dilemma, even leading to the administration of IV alteplase in cases that are later diagnosed as either MS or having an "MS flare."
|
30135678 |
2018 |
Acute Cerebrovascular Accidents
|
0.360 |
Biomarker
|
disease |
BEFREE |
In many countries, thrombolysis with intravenous alteplase has become a central part of acute stroke care in recent years, requiring radical restructuring of services.
|
28120326 |
2017 |
Acute Cerebrovascular Accidents
|
0.360 |
Biomarker
|
disease |
BEFREE |
We aimed to investigate the safety and efficacy of tenecteplase versus alteplase in patients with acute stroke who were eligible for intravenous thrombolysis.
|
28780236 |
2017 |
Acute Cerebrovascular Accidents
|
0.360 |
Biomarker
|
disease |
CTD_human |
Turning up the pressure on vascular disease.
|
25245553 |
2014 |
Acute Cerebrovascular Accidents
|
0.360 |
Therapeutic
|
disease |
CTD_human |
Turning up the pressure on vascular disease.
|
25245553 |
2014 |
Acute Cerebrovascular Accidents
|
0.360 |
Biomarker
|
disease |
CTD_human |
Lack of association between hyperglycaemia at arrival and clinical outcomes in acute stroke patients treated with tissue plasminogen activator.
|
20536612 |
2010 |
Acute Cerebrovascular Accidents
|
0.360 |
Biomarker
|
disease |
CTD_human |
Symptomatic intracerebral hemorrhage among eligible warfarin-treated patients receiving intravenous tissue plasminogen activator for acute ischemic stroke.
|
20212195 |
2010 |
Acute Cerebrovascular Accidents
|
0.360 |
Therapeutic
|
disease |
CTD_human |
Symptomatic intracerebral hemorrhage among eligible warfarin-treated patients receiving intravenous tissue plasminogen activator for acute ischemic stroke.
|
20212195 |
2010 |
Acute Cerebrovascular Accidents
|
0.360 |
Biomarker
|
disease |
CTD_human |
[Thrombolysis in acute ischemic stroke in basic hospitals. four cases reports].
|
20488584 |
2010 |
Acute Cerebrovascular Accidents
|
0.360 |
Therapeutic
|
disease |
CTD_human |
Early recurrent ischemic stroke complicating intravenous thrombolysis for stroke: incidence and association with atrial fibrillation.
|
20705933 |
2010 |
Acute Cerebrovascular Accidents
|
0.360 |
Therapeutic
|
disease |
CTD_human |
Lack of association between hyperglycaemia at arrival and clinical outcomes in acute stroke patients treated with tissue plasminogen activator.
|
20536612 |
2010 |
Acute Cerebrovascular Accidents
|
0.360 |
Therapeutic
|
disease |
CTD_human |
Time of day, outcome, and response to thrombolytic therapy: the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Trial experience.
|
20123226 |
2010 |
Acute Cerebrovascular Accidents
|
0.360 |
Biomarker
|
disease |
CTD_human |
Time of day, outcome, and response to thrombolytic therapy: the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Trial experience.
|
20123226 |
2010 |
Acute Cerebrovascular Accidents
|
0.360 |
Biomarker
|
disease |
CTD_human |
Early recurrent ischemic stroke complicating intravenous thrombolysis for stroke: incidence and association with atrial fibrillation.
|
20705933 |
2010 |
Acute Cerebrovascular Accidents
|
0.360 |
Therapeutic
|
disease |
CTD_human |
[Thrombolysis in acute ischemic stroke in basic hospitals. four cases reports].
|
20488584 |
2010 |
Acute Cerebrovascular Accidents
|
0.360 |
Biomarker
|
disease |
CTD_human |
A method to determine stroke trial success using multidimensional pooled control functions.
|
19286598 |
2009 |
Acute Cerebrovascular Accidents
|
0.360 |
Therapeutic
|
disease |
CTD_human |
A method to determine stroke trial success using multidimensional pooled control functions.
|
19286598 |
2009 |
Acute Cerebrovascular Accidents
|
0.360 |
Biomarker
|
disease |
CTD_human |
Importance of leukoaraiosis on CT for tissue plasminogen activator decision making: evaluation of the NINDS rt-PA Stroke Study.
|
18560214 |
2008 |
Acute Cerebrovascular Accidents
|
0.360 |
Therapeutic
|
disease |
CTD_human |
NXY-059 for the treatment of acute stroke: pooled analysis of the SAINT I and II Trials.
|
18369171 |
2008 |
Acute Cerebrovascular Accidents
|
0.360 |
Biomarker
|
disease |
CTD_human |
Intravenous recombinant tissue plasminogen activator improves arterial recanalization rates and reduces infarct volumes in patients with hyperdense artery sign on baseline computed tomography.
|
18346647 |
2008 |
Acute Cerebrovascular Accidents
|
0.360 |
Biomarker
|
disease |
CTD_human |
NXY-059 for the treatment of acute stroke: pooled analysis of the SAINT I and II Trials.
|
18369171 |
2008 |
Acute Cerebrovascular Accidents
|
0.360 |
Biomarker
|
disease |
CTD_human |
Symptomatic intracerebral hemorrhage and recanalization after IV rt-PA: a multicenter study.
|
18753474 |
2008 |